Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain

Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.836
https://www.valueinhealthjournal.com/article/S1098-3015(15)02912-5/fulltext
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 279
First Page : A385
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02912-5&doi=10.1016/j.jval.2015.09.836
HEOR Topics :
Tags :
Regions :